India to Chile: Bromhexine Export Trade Route

The India to Chile Bromhexine corridor is one of India's established pharmaceutical export routes, with 49 shipments documented worth a combined $601.2K USD. The route is dominated by SANPRAS HEALTHCARE PRIVATE LIMITED , which alone accounts for roughly 34% of all export value, reflecting the consolidated nature of India's bromhexine manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $12.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with bromhexine's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 13.4%, placing it at rank #1 among India's top bromhexine export destinations globally.

On the import side, key buyers of Indian bromhexine in Chile include OPKO CHILE S.A., , SEVEN PHARMA CHILE SPA.,, OPKO CHILE S,A, and 4 others. OPKO CHILE S.A., is the single largest importer with 14 shipments valued at $202.6K USD.

India's bromhexine exports to Chile are driven primarily by a handful of large-scale manufacturers. SANPRAS HEALTHCARE PRIVATE LIMITED with 14 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Chile benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SANPRAS HEALTHCARE PRIVATE LIMITED , BAROQUE PHARMACEUTICALS PVT LTD, SANPRAS HEALTHCARE PRIVATE LIMITED — together account for 93% of total trade value on this route. The average shipment value of $12.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as bromhexine syrup 4mg/5ml (bromhxina jbe. and bromhexine hydrochloride syrup 4mg/5ml,batch no-g013332,g013333,g013347,g013348,g013349,g013350,g013351,mfg.dt:10/2023, suggesting that buyers in Chile tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, OPKO CHILE S.A., is the largest importer with 14 shipments worth $202.6K USD — representing 34% of all bromhexine imports from India on this route. A total of 7 buyers are active on this corridor.